Tagged cdmo

Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation From Recipharm to Focus on the Transition to Low GWP pMDIs
Press Release

Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation From Recipharm to Focus on the Transition to Low GWP pMDIs

 Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site Read More
Pace® Life Sciences Acquires New Jersey Laboratory From Curia
Press Release

Pace® Life Sciences Acquires New Jersey Laboratory From Curia

 Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network Read More
Press Release

iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology

 iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102. Read More
Press Release

BioPharma Connections Adds LGM Pharma as a Strategic Client Partner

 LGM Pharma opts to engage with BioPharma Connections for business development services Read More
Northway Biotech Set to Launch Advanced Microbial and Mammalian GMP Facilities in Massachusetts
Press Release

Northway Biotech Set to Launch Advanced Microbial and Mammalian GMP Facilities in Massachusetts

 Read More
Forecyte Bio's Grand Opening of the CGMP Facility in Maryland
Press Release

Forecyte Bio's Grand Opening of the CGMP Facility in Maryland

 Forecyte Bio, CGT CDMO leader, officially opened its cGMP production suites for plasmid DNA, viral vector and cell therapy productions. Read More
Leadgene Utilizes LEADSPHERE™ Lyophilization Technology to Make Reagents Stable for Long-Term Logistics
Press Release

Leadgene Utilizes LEADSPHERE™ Lyophilization Technology to Make Reagents Stable for Long-Term Logistics

 Read More
JM Health Rebrands as Veranova Following Sale to Altaris Capital Partners
Press Release

JM Health Rebrands as Veranova Following Sale to Altaris Capital Partners

 Read More
Tadgh Prendeville to Assume the Role of President and CEO at Regis Technologies, Inc.
Press Release

Tadgh Prendeville to Assume the Role of President and CEO at Regis Technologies, Inc.

 Read More
CDMOs Recognized for Service and Leadership
Press Release

CDMOs Recognized for Service and Leadership

 Pharma and biotech customers select service providers for excellence in capabilities, expertise, quality, compatibility, reliability, and service Read More
Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services
Press Release

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

 Acquisition adds significant experience and expertise in the development of liquid, semi-solid, and oral solid dose products for pre-clinical and clinical use, allowing Pace to support a growing number of clients throughout the drug development process. Read More
Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area
Press Release

Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area

 Read More
Northway Biotechpharma, Biologics CDMO, Announces Company Brand Name Change to Northway Biotech
Press Release

Northway Biotechpharma, Biologics CDMO, Announces Company Brand Name Change to Northway Biotech

 Read More
Memo Therapeutics AG and Northway Biotechpharma Collaborate on the Fast-Track Manufacturing of a SARS-CoV-2-Neutralizing Antibody for the Therapy of COVID-19
Press Release

Memo Therapeutics AG and Northway Biotechpharma Collaborate on the Fast-Track Manufacturing of a SARS-CoV-2-Neutralizing Antibody for the Therapy of COVID-19

 Read More
Regis Technologies Now Offers Solid State Chemistry
Press Release

Regis Technologies Now Offers Solid State Chemistry

 Regis Technologies, a contract development and manufacturing organization for small molecule active pharmaceutical ingredients, announces a new Solid State Chemistry service. Read More
Regis Technologies' 2019 FDA Inspection Yields NAI Classification (Zero 483s)
Press Release

Regis Technologies' 2019 FDA Inspection Yields NAI Classification (Zero 483s)

 Regis Technologies, a contract development and manufacturing organization for small molecule active pharmaceutical ingredients, earned perfect results from its April 2019 FDA inspection. Read More
Press Release

Dr. Ralph Landau Appointed to the Role of President of Frontida BioPharm, Inc.

 Read More